Just over a year ago, we reported on a paper by Hearn et al. that had shown that a specific inherited mutation in the HSD3B1 gene seemed to be associated with a more aggressive form of prostate cancer that was less responsive to treatment with androgen deprivation therapy (ADT). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: 1245C, allele, CYP17A1, HSD3B1, inhibition, Treatment, variant | 2 Comments »
A recent article in the International Journal of Cancer lays out a possible future scenario for prostate cancer risk assessment that takes specific account of familial and hereditary risks for clinically significant prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: allele, Diagnosis, gene, heredity, market, mutation, risk | Leave a comment »
We know from a number of older, epidemiologic studies that there seems to be an inverse association between diabetes status and prostate cancer risk. In other words, people with diabetes seem to be less likely to be diagnosed with prostate cancer. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: allele, diabetes, genetics, genome, risk | Leave a comment »
We have reported separately on a study of the long-term durability of erectile function following brachytherapy using permanent seed implantation. Other reports today address:
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Prevention, Risk, Treatment | Tagged: allele, antiperspirant, biochemical recurrence, cause, communication, Diagnosis, Literacy, Prevention, PSA velocity, risk, salvage radical prostatectomy, tool | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 